Veru to report fiscal 2021 fourth-quarter, full-year financial results, host conference call on december 2nd

Miami, nov. 18, 2021 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, today announced that it will report financial results for its fiscal 2021 fourth quarter and full year ended september 30, 2021, on thursday, december 2, 2021, before the market opens. veru's management will host a conference call that same day at 8 a.m. et to review the company's performance and to answer questions. the call will also be accessible via webcast.
VERU Ratings Summary
VERU Quant Ranking